4
Total investments
2
Early stage
0
Mid stage
0
Late stage
6y
Years active
Portfolio
3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor & Senior Advisor
Jun 2023
At Skinopathy, our mission is to provide accessible healthcare on demand to everyone. This is to enable people to live healthier and longer lives by getting the care they need when they need it.
Founder✨Advisor✨Angel Investor
Jun 2023
Whether you are in the life sciences sector trying to deepen the adoption of your digital solutions, or at a tech company trying to get into the pharma space, we help you accelerate your commercialization journey.
Founded in 2023, our mission is to advance the use of life-changing technology in healthcare by bridging the gap between innovative startups and pharma companies.
Our experts have lived experience as senior executives in biopharma (in marketing, sales, medical affairs, regulatory, payor stakeholders and patient engagement) as well as in pharma/health tech. We’ve been around the block and know how to bring practical solutions to your tough challenges.
Were a scalable, no-nonsense resource that you can call on for discrete projects, or for guidance on the fly. We can also act as “fresh eyes”, and be your personal sounding board as you establish your path forward, turning your ideas into reality. We don’t like to stay forever --- we come and go as you need us. Expect a versatile, results-oriented approach with access to experts you don’t normally have in your current team.
Vice President, Commercial & Investor
Sep 2020
ODAIA is the leading AI company helping life sciences companies innovate their commercial engagement strategies using Customer Science. The company’s cloud solution, MAPTUAL, integrates data science, behavioral science, and AI to gain a deep understanding of healthcare professionals (HCPs) and their patient decisions across the entire customer journey.
Experience · 7 entries
All (7)
Investments (3)
Founder (1)
2024
Board Director, Leadership Team Member and Ambassador
Apr 2024
Canadian Entrepreneurs in Life Sciences (CELS) is a multi-dimensional, not-for-profit, organization supporting the advancement of innovative Canadian Life Science technology businesses in the San Francisco Bay Area through a range of services:
• Valley Ready Accelerator - qualify, coach and support high potential Canadian life science companies to a successful commercial endpoint and/or business success
• Mentoring - coach Canadian entrepreneurs 1 on 1; leverage mentor network for broader access to high quality and experienced LS leaders & influencers
• Showcase - promote Canadian LS technologies to the Bay Area community via other events/opportunities in the Valley, as well as invitation for venture firms and LS professionals to come up to Canada for industry related events
2023
Investor & Senior Advisor
Jun 2023
At Skinopathy, our mission is to provide accessible healthcare on demand to everyone. This is to enable people to live healthier and longer lives by getting the care they need when they need it.
Founder✨Advisor✨Angel Investor
Jun 2023
Whether you are in the life sciences sector trying to deepen the adoption of your digital solutions, or at a tech company trying to get into the pharma space, we help you accelerate your commercialization journey.
Founded in 2023, our mission is to advance the use of life-changing technology in healthcare by bridging the gap between innovative startups and pharma companies.
Our experts have lived experience as senior executives in biopharma (in marketing, sales, medical affairs, regulatory, payor stakeholders and patient engagement) as well as in pharma/health tech. We’ve been around the block and know how to bring practical solutions to your tough challenges.
Were a scalable, no-nonsense resource that you can call on for discrete projects, or for guidance on the fly. We can also act as “fresh eyes”, and be your personal sounding board as you establish your path forward, turning your ideas into reality. We don’t like to stay forever --- we come and go as you need us. Expect a versatile, results-oriented approach with access to experts you don’t normally have in your current team.
Investor & Senior Advisor
Apr 2023
Clinicom is at the forefront of mental health care innovation, offering an unparalleled platform designed to assess, monitor, and support the management of over 80 DSM conditions through a singular, adaptive assessment. Our unique application of augmented intelligence and machine learning sets us apart, making us the only comprehensive Mental Health Platform of our kind globally.
Our mission is to alleviate the clinical and administrative burdens associated with delivering high-quality mental health care. Clinicom enhances clinical workflows, making it easier for professionals to provide exceptional care without the traditional logistical challenges. Our platform is not only a tool for improving clinical efficiency; its a reimbursable solution that integrates seamlessly into care models, offering valuable insights into treatment and diagnostic analytics, and meticulously tracking treatment outcomes.
Clinicom is pioneering in its approach to offer a fully autonomous platform that significantly reduces the workload on clinical staff, thereby expanding patient access to vital mental health services. We are proud to be the first in behavioral health to deliver a comprehensive metric-based care system directly at your fingertips. This innovative approach not only lowers healthcare costs but also markedly enhances patient outcomes, setting a new standard in mental health care.
For professionals seeking to transform their practice with Clinicoms cutting-edge technology, please call us at 833-271-1325 or at clinicom.com. Join us in redefining mental health care for the better.
Mentor
Feb 2023
Creative Destruction Lab (CDL) is a nonprofit organization that delivers an objectives-based program for massively scalable, seed-stage, science- and technology-based companies.
The nine-month program employs an objectives-based mentoring process to enhance the performance of technical founders who learn from the insights of experienced entrepreneurs, with the goal of maximizing equity-value creation.
Founded by Professor Ajay Agrawal in 2012 at the University of Toronto’s Rotman School of Management, the program has expanded and now has 11 sites across six countries: Toronto, Vancouver, Calgary, Montreal, Halifax, Paris, Madison, Seattle, Estonia, Berlin, and Melbourne.
The program combines 5 elements to help companies transition from science projects to scalable and financeable companies:
- An emphasis on objective-setting, helping companies focus on what’s most important to their business
- Focused mentorship from experienced entrepreneurs who have founded, led, and sold significant tech companies
- Technical advice from world-leading scientists, engineers, and economists
- Hands-on support from top business students, who embed within the company to provide business support
- Opportunities to raise capital, including angels and VCs from Europe and North America
The successful commercialization of cutting-edge science and technology achieved through the program has led to the creation of over CAD $35 billion in equity value.
Show all 7 entries ↓
Investment activity
2020–2023 · 4 investments
Recent (last 2 years)Earlier
